The efficacy of alendronate in reducing the risk for vertebral fracture in japanese patients with osteoporosis: A randomized, double-blind, active-controlled, double-dummy trial-Reference-Cited by-同舟云学术

The efficacy of alendronate in reducing the risk for vertebral fracture in japanese patients with osteoporosis: A randomized, double-blind, active-controlled, double-dummy trial

Published:2002-09 Issue:9 Volume:63 Page:606-620
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Kazuhiro Kushida,Masataka Shiraki,Toshitaka Nakamura,Hideaki Kishimoto,Hirotoshi Morii,Kichizo Yamamoto,Kiyoshi Kaneda,Masao Fukunaga,Tetsuro Inoue,Mituyoshi Nakashima,Hajime Orimo

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference39 articles.

1. Guidelines for diagnosis and management of osteoporosis;Kanis;Osteoporosis Int,1997

2. The socioeconomic burden of fractures: Today and in the 21st century;Johnell;Am J Med,1997

3. Hip fractures in the elderly: A world-wide projection;Cooper;Osteoporosis Int,1992

4. Nationwide incidence survey of femoral neck fracture in Japan, 1992;Orimo;J Bone Miner Metab,1997

5. Clinical consequences of vertebral fractures;Ross;Am J Med,1997

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of bone mineral density in reducing fracture risk in patients receiving alendronate plus alfacalcidol therapy;Journal of Orthopaedic Science;2021-11

2. Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis;Archives of Endocrinology and Metabolism;2018-08

3. Spondylosis and Osteoporotic Vertebral Fractures;Osteoporosis in Orthopedics;2016

4. Time Course of Bone Mineral Density Changes With Denosumab Compared With Other Drugs in Postmenopausal Osteoporosis: A Dose-Response–Based Meta-Analysis;The Journal of Clinical Endocrinology & Metabolism;2014-10

5. Clinical Trials Express:Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT);The Journal of Clinical Endocrinology & Metabolism;2014-07-01